Literature DB >> 11375365

Establishing surveillance for diabetes in American Indian youth.

T S Harwell1, J M McDowall, K Moore, A Fagot-Campagna, S D Helgerson, D Gohdes.   

Abstract

OBJECTIVE: To determine prevalence estimates in order to monitor diabetes, particularly type 2 diabetes, in American Indian youth. RESEARCH DESIGN AND METHODS: To explore the feasibility of developing a case definition using information from primary care records, all youth aged <20 years with an outpatient visit or hospitalization for diabetes were identified from the Billings Area Indian Health Service database in Montana and Wyoming from 1997 to 1999, and the medical records were reviewed. Classification for probable type 1 diabetes was based on age < or =5 years, weight per age < or =15th percentile at diagnosis, or positive results of islet cell antibody test. Classification for probable type 2 diabetes was based on weight per age > or =85th percentile or presence of acanthosis nigricans at diagnosis, elevated C-peptide or insulin, family history for type 2 diabetes, or use of oral hypoglycemic agents with or without insulin or absence of current treatment 1 year after diagnosis.
RESULTS: A total of 52 case subjects with diabetes were identified, 3 of whom had diabetes secondary to other conditions. Of the remaining 49 case subjects, 25 (51%) were categorized as having probable type 2 diabetes, 14 (29%) as having probable type 1 diabetes, and 10 (20%) could not be categorized because of missing or negative information. Prevalence estimates for diabetes of all types, type 1 diabetes, and type 2 diabetes were 2.3, 0.6, and 1.1, respectively, per 1,000 youth aged <20 years.
CONCLUSIONS: Our definitions may be useful for surveillance in primary care settings until further studies develop feasible case definitions for monitoring trends in diabetes among youth.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11375365     DOI: 10.2337/diacare.24.6.1029

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  4 in total

Review 1.  Clinical review: Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review.

Authors:  Sherita H Golden; Karen A Robinson; Ian Saldanha; Blair Anton; Paul W Ladenson
Journal:  J Clin Endocrinol Metab       Date:  2009-06       Impact factor: 5.958

Review 2.  Twenty years of pediatric diabetes surveillance: what do we know and why it matters.

Authors:  Dana Dabelea; Katherine A Sauder; Elizabeth T Jensen; Amy K Mottl; Alyssa Huang; Catherine Pihoker; Richard F Hamman; Jean Lawrence; Lawrence M Dolan; Ralph D' Agostino; Lynne Wagenknecht; Elizabeth J Mayer-Davis; Santica M Marcovina
Journal:  Ann N Y Acad Sci       Date:  2021-02-05       Impact factor: 6.499

Review 3.  Young-onset type 2 diabetes mellitus - implications for morbidity and mortality.

Authors:  Dianna J Magliano; Julian W Sacre; Jessica L Harding; Edward W Gregg; Paul Z Zimmet; Jonathan E Shaw
Journal:  Nat Rev Endocrinol       Date:  2020-03-20       Impact factor: 43.330

Review 4.  Diabetes in Montana's Indians: the epidemiology of diabetes in the Indians of the Northern Plains and Canada.

Authors:  Dorothy Gohdes; Carrie S Oser; Todd S Harwell; Kelly R Moore; Janet M McDowall; Steven D Helgerson
Journal:  Curr Diab Rep       Date:  2004-06       Impact factor: 5.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.